Just read the following article in today's paper:
QUOTE
Baxalta accepts US$ 32b bid from Shire
Dublin-based pharmaceutical group Shire has agreed to buy US peer Baxalta for US$ 32 billion in a deal aimed at forming a global biotech giant targeting rare diseases. The agreed cash-and-share offer was an improvement on a previous hostile bid of US$ 3o billion that Baxalta rejected in August. The purchase of the Illinois-based group will boost Shire's position in the market for rare-disease treatments in the pharmaceutical sector, which is undergoing a rapid consolidation.
"This proposed combination allows us to realise our vision of building the leading biotechnology company focused on rare diseases", Shire chief executive Flemming Ornskov said in a statement. "Our expanded portfolio and presence in more than 100 countries will drive our growth to over US$ 20 billion in anticipated annual revenues by 2020," he added.
AFP
END OF QUOTE
Makes - JIMHO - for happy reading to any holder of NEU.
wasa
- Forums
- ASX - By Stock
- NEU
- this should be relevant to NEU's valuation, I would think...
this should be relevant to NEU's valuation, I would think...
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 249 | $20.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.31 | 790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 249 | 20.150 |
5 | 650 | 20.000 |
3 | 776 | 19.900 |
6 | 2760 | 19.800 |
1 | 400 | 19.780 |
Price($) | Vol. | No. |
---|---|---|
20.680 | 888 | 1 |
20.800 | 500 | 1 |
20.900 | 500 | 1 |
21.000 | 2200 | 3 |
21.200 | 611 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |